Biotech investors in the United States
Updated 16 Nov 2026
Venture funds
40 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | SOSV SOSV provides early-stage funding for healthcare and environmental technologies, with recent investments including Opentrons and Prolific Machines. Princeton, United States |
Hardware, Artificial intelligence | Seed, Early stage venture | 41% | 17 |
| 2 | SOSV SF & NY (Fka IndieBio) SOSV SF & NY, formerly IndieBio, supports deep tech founders, with recent investments including Prolific Machines and heXem bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture | 3% | 14 |
| 3 | Alumni Ventures Alumni Ventures offers accredited investors diversified startup portfolios, with recent investments including Coframe and Ocient. Manchester, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 1% | 7 |
| 4 | Khosla Ventures Khosla Ventures backs AI, sustainability, health and frontier technologies, with recent investments including Opentrons and Ramp. Menlo Park, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 39% | 7 |
| 5 | Alexandria Venture Investments Alexandria Venture Investments invests in real estate technology and healthcare, with recent investments including Lycia Therapeutics and Aspen Neuroscience. Pasadena, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 7% | 5 |
| 6 | Mission BioCapital Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio. Cambridge, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 20% | 4 |
| 7 | Bristol-Myers Squibb Bristol-Myers Squibb develops and sells pharmaceuticals, with recent investments including BigHat Biosciences and Ratio Therapeutics. New York, United States |
Biotech, Health care | Early stage venture | 30% | 4 |
| 8 | Gaingels Gaingels funds startups and supports diversity and inclusion in entrepreneurship, with recent investments including Delix Therapeutics and Ocient. Burlington, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 1% | 4 |
| 9 | Google Ventures Google Ventures provides seed through growth-stage funding to technology companies, with recent investments including Harvey and SambaNova. San Francisco, United States |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 4 |
| 10 | ARCH Venture Partners ARCH Venture Partners focuses on life science discoveries to prevent, detect and cure disease, with recent companies including Moonwalk Biosciences and Mirador Therapeutics. Chicago, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 3 |
| 11 | Conscience VC Conscience VC invests in science, with recent companies Tiny Health and Integrated Biosciences. Austin, United States |
Health care, Biotech | Seed, Early stage venture | 8% | 3 |
| 12 | Fifty Years Fifty Years backs entrepreneurs solving the world's biggest problems, recently investing in Multiply Labs and Aalo Atomics. San Francisco, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 19% | 3 |
| 13 | Joyance Partners Joyance Partners invests in companies using science and technology to cultivate joy, with recent investments including Mosh and Sparxell. San Francisco, United States |
Health care, Biotech | Seed, Early stage venture | 8% | 3 |
| 14 | Modi Ventures Modi Ventures focuses on investing into the next frontier, and recently backed Tiny Health and Latus Bio. Houston, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 14% | 3 |
| 15 | Pfizer Pfizer is a biopharmaceutical company developing medicines and vaccines, with recent companies including Circle Pharma, CellCentric and FoRx Therapeutics. New York, United States |
Biotech, Health care | 40% | 3 | |
| 16 | The Column Group The Column Group is a venture firm dedicated to biotechnology companies, with recent companies including Circle Pharma, InduPro and Atavistik Bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 39% | 3 |
| 17 | 2048 Ventures 2048 Ventures is a thesis-driven venture firm, recently backing TwoStep Therapeutics and Genius AI. New York, United States |
Artificial intelligence, Fintech | Seed, Early stage venture | 67% | 2 |
| 18 | 8VC 8VC structures capital deployments for technology companies, with recent investments including Sirona Medical and BigHat Biosciences. Austin, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 30% | 2 |
| 19 | Alpha Wave Global Alpha Wave Global operates across private equity, private credit, public markets and insurance, with recent investments in Moonwalk Biosciences and Cour Pharmaceuticals Development. Miami, United States |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 20 | Artis Ventures Artis Ventures invests in companies at the intersection of technology, health and biology, including Delix Therapeutics and Ozlo Sleep. San Francisco, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 35% | 2 |
| 21 | BoxGroup BoxGroup invests in early-stage technology companies, with recent investments including Nominal and Northwood Space. New York, United States |
Artificial intelligence, Fintech | Seed, Early stage venture | 5% | 2 |
| 22 | Builders VC Builders VC invests where technology meets new business models to modernize antiquated industries, including Clay and Pie Systems. San Francisco, United States |
Artificial intelligence, Health care | Early stage venture | 34% | 2 |
| 23 | Casdin Capital Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care. New York, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 15% | 2 |
| 24 | DCVC DCVC invests in venture and private equity strategies, with recent backings including Mach Industries and Fortem Technologies. Palo Alto, United States |
Artificial intelligence, Hardware | Seed, Early stage venture | 19% | 2 |
| 25 | Decheng Capital Decheng Capital provides capital to early and growth stage life science companies, with recent investments in YolTech Therapeutics and Phrontline Biopharma. Menlo Park, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 40% | 2 |
| 26 | Digitalis Ventures Digitalis Ventures invests in solutions to complex problems in human and animal health, including T-Therapeutics and Reema Health. New York, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 16% | 2 |
| 27 | Dolby Family Ventures Dolby Family Ventures backs early-stage technology companies, with recent investments including Delix Therapeutics, NeuroBionics and Ursa Major. San Francisco, United States |
Hardware, Health care | Seed, Early stage venture, Late stage venture | 7% | 2 |
| 28 | Everywhere Ventures Everywhere Ventures invests in early-stage technology companies, with recent investments including VAMA and North.cloud. New York, United States |
Artificial intelligence, Fintech | Early stage venture | 2% | 2 |
| 29 | F-Prime F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics. Cambridge, United States |
Health care, Fintech | Seed, Early stage venture, Late stage venture | 25% | 2 |
| 30 | Founders Fund Founders Fund backs companies building new technologies, and recent investments include Nominal and Northwood Space. San Francisco, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 31% | 2 |
| 31 | FoundersX Ventures FoundersX Ventures is an AI-first venture capital firm, with recent companies Zafrens and Cognito Therapeutics. Menlo Park, United States |
Hardware, Artificial intelligence | Early stage venture | 14% | 2 |
| 32 | Insight Partners Insight Partners invests in high-growth software and Internet startups, with recent investments including Coast and Reco. New York, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 62% | 2 |
| 33 | LifeX Ventures LifeX Ventures backs technologies that extend the longevity of people and planet, with recent companies including Dash Bio and Century Health. New York, United States |
Artificial intelligence, Health care | 11% | 2 | |
| 34 | MassVentures MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy. Boston, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 26% | 2 |
| 35 | Morningside Morningside invests in companies with novel science and technology, recently backing Pelicargo and Cognito Therapeutics. Newton, United States |
Health care, Biotech | 46% | 2 | |
| 36 | Pareto Holdings Pareto Holdings provides venture studio and early-stage funding services, with recent investments including Mural and Ryft. New York, United States |
Fintech, Artificial intelligence | Seed, Early stage venture | 2% | 2 |
| 37 | Pear VC Pear VC focuses on pre-seed and seed technology companies, with recent companies including ImpriMed, Cognition and WindBorne Systems. Menlo Park, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 19% | 2 |
| 38 | Prime Movers Lab Prime Movers Lab invests in energy, transportation, infrastructure, manufacturing, human augmentation and agriculture, including Zafrens and Cognixion. Jackson, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 68% | 2 |
| 39 | Tau Ventures Tau Ventures invests in digital health and automation companies such as cars, drones and robots, with recent backings including Biotia and Verbal. Palo Alto, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 5% | 2 |
| 40 | The Engine The Engine supports new companies working on scientific and technological innovation, with recent companies including Hyperlight and Emvolon. Cambridge, United States |
Hardware, Health care | Seed, Early stage venture | 36% | 2 |
Table 1. Biotech investors in the United States: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Y Combinator | Startup accelerator | Mountain View, United States | •••@ycombinator.com | (415) ••• |
| SOSV | Venture capital firm | Princeton, United States | •••@sosv.com | |
| National Science Foundation | Entrepreneurship program | Alexandria, United States | •••@nsf.gov | (703) ••• |
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | •••@sosv.com | |
| Alumni Ventures | Angel group | Manchester, United States | •••@av.vc | +1 603••• |
| MassChallenge | Startup accelerator | Boston, United States | •••@masschallenge.org | |
| Techstars | Startup accelerator | New York, United States | •••@techstars.com | +1 303••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Y Combinator | G••• A••• | General Partner | g•••@ycombinator.com | In the CSV |
| SOSV | O••• R••• | Managing General Partner | o•••@sosv.com | In the CSV |
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| OrbiMed | W••• P••• | Managing Director | p•••@orbimed.com | In the CSV |
| Techstars | A••• B••• | Managing Director NYC Programs | a•••@techstars.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 314 of the 441 biotech investors in the United States have a published email address, 282 a phone number and 429 a website.
- Y Combinator has the most recorded investments, 8,719, 3,692 of them as lead investor.
- 311 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Y Combinator is an investor in 225 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Light Frame's $5.1M seed round on 10 November 2026.
- Software is the most common sector across their 19,521 portfolio companies (80%).
- Early stage venture is the most common investment stage, recorded for 400 of them (91%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in the United States
30 of 441, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | Artificial intelligence, Fintech | Kalshi, Opentrons, Reflex | 225 | 8,719 | 3,692 | 783 | •••@ycombinator.com | (415) ••• | In the CSV |
| 2 | SOSV | Venture capital firm | Princeton, United States | Hardware, Artificial intelligence | Opentrons, live2.ai, Prolific Machines | 30 | 2,865 | 1,185 | 98 | •••@sosv.com | In the CSV | |
| 3 | National Science Foundation | Entrepreneurship program, Government investment office | Alexandria, United States | Hardware, Artificial intelligence | Emvolon, Xona, MuukTest | 36 | 4,642 | 4,419 | 269 | •••@nsf.gov | (703) ••• | In the CSV |
| 4 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 5 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | Biotech, Health care | Prolific Machines, heXem bio, BryoSphere | 17 | 596 | 17 | 12 | •••@sosv.com | In the CSV | |
| 6 | Alumni Ventures | Angel group, Micro VC fund | Manchester, United States | Artificial intelligence, Fintech | Coframe, Ocient, Formic | 67 | 2,424 | 32 | 263 | •••@av.vc | +1 603••• | In the CSV |
| 7 | OrbiMed | Private equity firm | New York, United States | Health care, Biotech | Triveni Bio, Windward Bio, Terremoto Biosciences | 8 | 810 | 276 | 304 | +1 (21••• | In the CSV | |
| 8 | MassChallenge | Startup accelerator | Boston, United States | Artificial intelligence, Health care | HELIOS, DrizzleX, ScribeUp | 26 | 3,225 | 1,037 | 267 | •••@masschallenge.org | In the CSV | |
| 9 | Techstars | Startup accelerator | New York, United States | Artificial intelligence, Fintech | Zipline International, Intuitivo, MuukTest | 67 | 6,842 | 3,391 | 638 | •••@techstars.com | +1 303••• | In the CSV |
| 10 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | Biotech, Health care | TwoStep Therapeutics, Lycia Therapeutics, Triveni Bio | 5 | 318 | 21 | 68 | •••@gmail.com | 626.57••• | In the CSV |
| 11 | Plug and Play | Startup accelerator, Co-working space | Sunnyvale, United States | Artificial intelligence, Fintech | Opsin, Helical Fusion, Reco | 51 | 2,592 | 352 | 230 | •••@pnptc.com | +1 408••• | In the CSV |
| 12 | ARCH Venture Partners | Venture capital firm | Chicago, United States | Health care, Biotech | Moonwalk Biosciences, Moleculent, Mirador Therapeutics | 3 | 535 | 147 | 121 | •••@archventure.com | 773-38••• | In the CSV |
| 13 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | Artificial intelligence, Fintech | Shield AI, Zipline International, Northwood Space | 49 | 2,041 | 916 | 311 | •••@a16z.com | (650) ••• | In the CSV |
| 14 | Khosla Ventures | Venture capital firm | Menlo Park, United States | Artificial intelligence, Health care | Coframe, Opentrons, Even Healthcare | 25 | 1,479 | 575 | 208 | •••@khoslaventures.com | +1 650••• | In the CSV |
| 15 | Google Ventures | Corporate venture arm, Venture capital firm | San Francisco, United States | Artificial intelligence, Hardware | Snorkel AI, Thatch, Harvey | 20 | 1,331 | 392 | 304 | In the CSV | ||
| 16 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | Health care, Biotech | Ramona, Talus Bio, Samay | 5 | 1,049 | 774 | 107 | •••@od.nih.gov | 301-49••• | In the CSV |
| 17 | Bristol-Myers Squibb | Venture capital firm | New York, United States | Biotech, Health care | BigHat Biosciences, Ratio Therapeutics, Cour Pharmaceuticals Development | 4 | 109 | 33 | 22 | (212)5••• | In the CSV | |
| 18 | MedTech Innovator | Startup accelerator | Los Angeles, United States | Health care, Biotech | StimCardio, Dopl Technologies, INIA Biosciences | 15 | 444 | 242 | 28 | •••@medtechinnovator.org | 310-70••• | In the CSV |
| 19 | Versant Ventures | Venture capital firm | Menlo Park, United States | Biotech, Health care | Gate Bioscience, Borealis Biosciences, Kate Therapeutics | 387 | 108 | 114 | +1 415••• | In the CSV | ||
| 20 | F-Prime | Venture capital firm | Cambridge, United States | Health care, Fintech | T-Therapeutics, Albert Invent, Immuneel Therapeutics | 4 | 540 | 133 | 113 | •••@fprimecapital.com | In the CSV | |
| 21 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | Hardware, Artificial intelligence | Pathos, Together AI, Union.ai | 5 | 2,398 | 826 | 670 | •••@nea.com | (650) ••• | In the CSV |
| 22 | 500 Global | Startup accelerator, Micro VC fund | Palo Alto, United States | Fintech, Commerce | Takenos, Daytona, Salary Hero | 27 | 3,424 | 579 | 469 | •••@500.co | +1 415••• | In the CSV |
| 23 | Insight Partners | Private equity firm, Venture capital firm | New York, United States | Artificial intelligence, Fintech | Coast, Reco, Island | 17 | 1,349 | 833 | 335 | •••@insightpartners.com | 212-23••• | In the CSV |
| 24 | Big Idea Ventures | Startup accelerator, Micro VC fund | New York, United States | Biotech, Health care | Standing Ovation, Seprify, Innocent Meat | 3 | 194 | 110 | 9 | •••@bigideaventures.com | (415) ••• | In the CSV |
| 25 | Gaingels | Syndicate, Venture capital firm | Burlington, United States | Artificial intelligence, Fintech | Delix Therapeutics, Ocient, Xona | 24 | 1,384 | 10 | 146 | +1 212••• | In the CSV | |
| 26 | Invus | Private equity firm | New York, United States | Health care, Biotech | Lycia Therapeutics, Triveni Bio | 2 | 300 | 52 | 99 | •••@invus.com | +1 (21••• | In the CSV |
| 27 | Polaris Partners | Private equity firm, Venture capital firm | Boston, United States | Health care, Artificial intelligence | Faro AI, Triveni Bio, Whisker Labs | 3 | 754 | 215 | 207 | •••@polarispartners.com | +1 855••• | In the CSV |
| 28 | Fidelity | Investment bank | Boston, United States | Health care, Hardware | Zipline International, Tenstorrent, SiMa.ai | 7 | 586 | 178 | 285 | +1-866••• | In the CSV | |
| 29 | Newchip Accelerator | Startup accelerator, Startup incubator | Austin, United States | Artificial intelligence, Fintech | Aerial Vantage, Evia Bio, Roboligent | 8 | 1,278 | 26 | 17 | •••@newchip.com | 512-39••• | In the CSV |
| 30 | DCVC | Venture capital firm | Palo Alto, United States | Artificial intelligence, Hardware | ZwitterCo, Mach Industries, Alchemab Therapeutics | 6 | 553 | 103 | 124 | •••@dcvc.com | (415) ••• | In the CSV |
Table 2. Biotech investors in the United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 441.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Y Combinator | Mountain View, United States | 225 | 3,060 | Kalshi, Opentrons, Reflex |
| 2 | Alumni Ventures | Manchester, United States | 67 | 696 | Coframe, Ocient, Formic |
| 3 | Techstars | New York, United States | 67 | 2,132 | Zipline International, Intuitivo, MuukTest |
| 4 | Plug and Play | Sunnyvale, United States | 51 | 740 | Opsin, Helical Fusion, Reco |
| 5 | Andreessen Horowitz | Menlo Park, United States | 49 | 462 | Shield AI, Zipline International, Northwood Space |
| 6 | General Catalyst | San Francisco, United States | 38 | 344 | Nominal, Tractian, StockGro |
| 7 | National Science Foundation | Alexandria, United States | 36 | 244 | Emvolon, Xona, MuukTest |
| 8 | Sequoia Capital | Menlo Park, United States | 32 | 429 | Zipline International, Kalshi, Hex Technologies |
| 9 | Lightspeed Venture Partners | Menlo Park, United States | 31 | 378 | Casap, Supabase, Snorkel AI |
| 10 | SOSV | Princeton, United States | 30 | 356 | Opentrons, live2.ai, Prolific Machines |
| 11 | Tiger Global Management | New York, United States | 27 | 289 | Harbinger, Easol, Mach9 |
| 12 | 500 Global | Palo Alto, United States | 27 | 1,023 | Takenos, Daytona, Salary Hero |
| 13 | Liquid 2 Ventures | San Francisco, United States | 26 | 313 | Zafrens, Tractian, Mach9 |
| 14 | MassChallenge | Boston, United States | 26 | 325 | HELIOS, DrizzleX, ScribeUp |
| 15 | Accel | Palo Alto, United States | 26 | 481 | Simplismart, Coast, RapidCanvas |
Table 3. Biotech investors in the United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Light Frame | Light Frame builds core banking and portfolio management technology for wealth managers. | Fintech | Providence, United States | Seed | $5.1M | 2026-11-10 | $6.8M | Half Court Ventures | 1 to 10 | 2024 |
| Nominal | Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. | Software | Los Angeles, United States | Series C | $240.0M | 2026-11-09 | $422.5M | General Catalyst, Founders Fund, Lux Capital +2 | 251 to 500 | 2022 |
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management, Dolby Family Ventures, Artis Ventures +1 | 11 to 50 | 2019 |
| Coframe | Coframe builds software that continuously improves websites and apps based on real-world performance data. | Artificial intelligence | San Francisco, United States | Series A | $25.0M | 2026-11-09 | $34.3M | Alumni Ventures, Khosla Ventures, Soma Capital | 11 to 50 | 2023 |
| Shield AI Unicorn | Shield AI develops AI-powered systems that enhance safety for service members and civilians. | Artificial intelligence | San Diego, United States | Series H | $2.0B | 2026-11-05 | $6.1B | Andreessen Horowitz | 1,001 to 5,000 | 2015 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity, Techstars, Andreessen Horowitz +2 | 1,001 to 5,000 | 2011 |
| CesiumAstro | CesiumAstro develops satellite communication systems and spacecraft solutions for aerospace, commercial, and defense customers. | Hardware | Austin, United States | Series D | $630.0M | 2026-11-05 | $1.7B | Trousdale Ventures | 501 to 1,000 | 2017 |
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Digitalis Ventures | 51 to 100 | 2022 |
| Ocient | Ocient analyzes petabyte to exabyte scale data sets for organizations. | Hardware | Chicago, United States | Series C | $100.0M | 2026-11-05 | $256.5M | Valor Equity Partners, Alumni Ventures, Gaingels | 101 to 250 | 2016 |
| Firmly.ai | Firmly.ai operates an agentic commerce platform for product discovery and checkout across AI and digital channels. | Fintech | Seattle, United States | Series A | $15.0M | 2026-11-05 | $17.0M | FJ Labs | 51 to 100 | 2019 |
Table 4. Biotech investors in the United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 15,639 | 80% |
| Artificial intelligence | 5,123 | 26% |
| Fintech | 3,465 | 18% |
| Hardware | 2,881 | 15% |
| Health care | 2,521 | 13% |
| Commerce | 2,275 | 12% |
| Cybersecurity | 1,009 | 5% |
| Biotech | 1,004 | 5% |
| Education | 963 | 5% |
| Energy | 322 | 2% |
Table 5. Biotech investors in the United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 400 | 91% |
| Seed investors | 346 | 78% |
| Late stage investors | 244 | 55% |
| Venture investors | 219 | 50% |
| Private equity investors | 86 | 20% |
| Post IPO investors | 79 | 18% |
| Convertible note investors | 67 | 15% |
| Debt investors | 51 | 12% |
Table 6. Biotech investors in the United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in the United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 38 | 9% |
| 2010s | 200 | 47% |
| 2000s | 93 | 22% |
| 1990s | 46 | 11% |
| 1980s | 22 | 5% |
| 1970s | 9 | 2% |
Table 8. Biotech investors in the United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in the United States. On 16 November 2026 that is 441 investors.
- 314 rows carry an email address and 282 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 441 rows: 12 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in the United States are on the list?
- 441, in the file dated 16 November 2026. 311 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 314 of the 441 carry an email address in the download and 282 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 441 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 441 rows, 314 firm email addresses and 282 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 219 of the 314 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.